(Q67555831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

A pilot study of 2',3'-dideoxyinosine for the treatment of chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

1 reference

M. W. Fried

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

J. C. Korenman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

A. M. Di Bisceglie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

Y. Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

J. G. Waggoner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

H. Mitsuya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

N. R. Hartman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

R. Yarchoan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

S. Broder

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

J. H. Hoofnagle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1398494

22 September 2022

language of work or name

English

0 references

publication date

1 October 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

861-864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Molecular targets for AIDS therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

An in vitro system for screening anti-hepatitis B virus drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840160402

7 January 2021

Identifiers

DOI

10.1002/HEP.1840160402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1398494%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference